Patient guide

Ultrasound-Guided Thyroid FNA Biopsy

Fine-needle aspiration uses a thin needle to collect cells from a thyroid nodule so a cytopathologist can examine them.

Not every nodule needs a biopsy
Ultrasound guides accurate needle placement
Results guide the next step

What is a thyroid FNA biopsy?

Fine-needle aspiration, commonly called FNA or FNAB, is a procedure that removes a small sample of cells from a thyroid nodule. Ultrasound is usually used to guide the needle into the intended area.

The sample is examined under a microscope. FNA does not remove the nodule and does not by itself treat it.

When might FNA be recommended?

The decision depends on the nodule's ultrasound appearance and size, thyroid blood tests, symptoms, medical history, and other risk factors. Some nodules can be monitored without biopsy.

A “cold nodule” is not a diagnosis

A nonfunctioning, or cold, nodule can be benign or malignant. A cold scan result alone does not determine whether biopsy is needed.

How should patients prepare?

  • Tell the clinical team about all medicines and supplements, especially anticoagulants or antiplatelet medicines.
  • Do not stop a prescribed medicine unless the prescribing or procedural clinician gives specific instructions.
  • Ask whether eating and drinking are permitted. Fasting is often unnecessary when sedation is not planned, but facility instructions vary.
  • Wear comfortable clothing and remove necklaces or other items around the neck.
  • Report allergies, bleeding problems, pregnancy, or any previous difficulty with procedures.

Will I be awake during a thyroid biopsy?

Most adults are awake during a thyroid FNA biopsy. Sedation or general anesthesia is not usually needed. Numbing medicine may be used at the biopsy site. Tell the clinical team before your appointment if you feel anxious about the biopsy or have trouble keeping still.

What happens during the biopsy?

The patient usually lies on the back with the neck gently extended. The skin is cleaned, and a local or topical anesthetic may be used. The clinician watches the needle on ultrasound while collecting cells from selected parts of the nodule.

More than one sample may be needed. Patients are commonly asked to remain still and avoid talking, coughing, or swallowing while the needle is in place. Pressure is applied to the biopsy site afterward.

Does a thyroid biopsy hurt?

A thyroid FNA biopsy is usually well tolerated, but discomfort varies. You may feel pressure from the ultrasound probe and brief discomfort as samples are taken. Numbing medicine may be used. Tell the clinician if you are uncomfortable.

How long does a thyroid biopsy take?

A thyroid FNA biopsy usually takes less than 30 minutes. The full visit may take longer for preparation and any observation afterward. Ask the facility how much time to allow for your appointment.

What happens after FNA?

Mild soreness or bruising can occur. The facility should provide instructions about activity, discomfort, medicines, and when to seek help.

Contact the clinical team promptly for expanding neck swelling, persistent bleeding, trouble breathing or swallowing, fever, or worsening pain. Emergency symptoms require urgent care.

What do thyroid biopsy results mean?

Many laboratories use the Bethesda System to group thyroid biopsy results into six categories. Your clinician interprets the result alongside your ultrasound findings, symptoms, and medical history.

  • Nondiagnostic (Bethesda I). The sample does not provide enough information for a diagnosis. This is not a benign result. Another ultrasound-guided biopsy is often needed.
  • Benign (Bethesda II). The sampled cells look noncancerous. Follow-up depends on the ultrasound findings and other clinical features. Read about monitoring a thyroid nodule.
  • Atypia of undetermined significance (Bethesda III). Some cells look unusual, but the sample cannot be classified as benign or cancerous.
  • Follicular neoplasm (Bethesda IV). “Neoplasm” means a growth of cells. In this category, the growth may be benign or cancerous. A needle biopsy alone cannot reliably tell the difference.
  • Suspicious for malignancy (Bethesda V). The sample is concerning for cancer, but does not establish a definite diagnosis. Your care team will discuss further evaluation and treatment planning.
  • Malignant (Bethesda VI). Cancerous cells were identified. Your care team will discuss the cancer type, any further evaluation, and treatment choices.

Categories III and IV are often called indeterminate, meaning the result is inconclusive. Depending on the category and other findings, your clinician may discuss repeat biopsy, molecular testing, or surgery.

If your result is suspicious or malignant, read the thyroid cancer guide for background on diagnosis and treatment planning.

When can molecular testing help?

If a biopsy result is indeterminate, molecular testing may help estimate whether the nodule is cancerous and guide a choice between monitoring and surgery. These tests examine genetic changes or patterns in cells from the nodule. They are not needed for every thyroid nodule.

A low-risk result may support ultrasound monitoring, but it does not rule out cancer completely. A suspicious result does not always mean cancer. Your clinician interprets the test alongside the biopsy, ultrasound findings, and your preferences.

Will I need another biopsy for molecular testing?

Not always. Your clinician and the pathology laboratory can check whether material from your first biopsy is suitable:

  • A sample saved at the first biopsy. An additional sample may have been collected and stored for possible molecular testing.
  • Existing biopsy slides. Some tests can use cells from the slides already prepared. Whether this is possible depends on the test and the amount and condition of the cells.
  • A new sample. If suitable material is unavailable and testing would help guide care, another ultrasound-guided biopsy may be discussed.

Before a biopsy, ask whether a sample should be saved in case molecular testing is needed. If you already have an indeterminate result, ask whether your existing sample or slides can be used. Ask about insurance coverage and your expected cost before the test is sent.

If you are worried about another biopsy, tell your care team so they can explain the options and discuss ways to make the procedure more comfortable.

When and how will I get my results?

Results commonly take a few days to two weeks, but timing varies. Your clinician will explain the findings and next steps.

Before leaving, ask who will contact you and when. If you have not heard by the expected time, contact the clinical team.

For practical support with uncertainty, read worry and next steps after finding a thyroid nodule.

What are the limitations and risks?

FNA is generally well tolerated, but no test is perfect. A sample may not contain enough cells, and a benign result does not eliminate the need for follow-up when ultrasound or clinical findings remain concerning.

Possible complications include pain, bruising, bleeding, infection, or temporary voice symptoms. Serious complications are uncommon. Individual risk may be different for patients with bleeding disorders or medicines that affect clotting.

Questions to ask the clinical team

  • Why does this nodule need biopsy?
  • Which ultrasound findings influenced the recommendation?
  • Should I change any medicines before the procedure?
  • Will local anesthetic be used?
  • How many samples may be collected?
  • How and when will I receive the result?
  • What follow-up is needed for each possible result?
  • If molecular testing would help, can my existing sample or slides be used?

Sources and medical review

Medically reviewed by Richard B. Guttler, MD, FACP, FACE, ECNU